{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:06:09Z","timestamp":1793253969206,"version":"4.5.0"},"reference-count":33,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-23-IAHU-0004"],"award-info":[{"award-number":["ANR-23-IAHU-0004"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["mBio"],"published-print":{"date-parts":[[2026,6,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Invasive mold diseases (IMDs) such as mucormycosis and aspergillosis carry high mortality despite optimal antifungal therapy. Adjunctive immunomodulation, including anti-PD-1 antibodies and interferon-\u03b3, may help restore antifungal immunity in severely ill patients. We implemented multidisciplinary team meetings in France to assess and validate the use of adjunctive anti-PD-1 monoclonal antibodies and interferon-\u03b3 in combination with antifungal therapy for patients with life-threatening IMDs. Here, we report the characteristics and outcomes of the treated patients. Twelve cases were reviewed, and eight patients ultimately received adjunctive therapy. All presented with particularly severe IMDs, including seven mucormycosis (three cerebral, three intra-abdominal, and one extensive fasciitis) and one pulmonary aspergillosis. PD-1 expression on T cells was elevated in all patients. Following adjunctive treatment, six of the eight patients survived. Therapy was generally well tolerated; serious adverse events included one episode of cutaneous toxicity and two cases of acute respiratory distress syndrome, possibly related to immunotherapy. All resolved after treatment discontinuation. In our experience, adjunctive immunotherapy combined with antifungals was mostly associated with favorable outcomes in severe, refractory IMDs. These findings support further investigation of host-directed strategies as potential adjuncts in managing life-threatening fungal diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>IMPORTANCE<\/jats:title>\n                    <jats:p>This study provides preliminary evidence supporting the clinical relevance of host-directed immunotherapy as an adjunct to antifungal treatment in severe invasive mold diseases (IMDs), which remain associated with high mortality despite optimized antifungal regimens. By targeting immune dysfunction, particularly T-cell exhaustion mediated through the PD-1 pathway, the combined use of anti-PD-1 monoclonal antibodies and interferon-\u03b3 aims to restore effective antifungal immune responses. The observed survival benefit in this small cohort supports the biological rationale that reversing immune paralysis can enhance pathogen clearance in patients with IMDs. Although limited by sample size, this work provides encouraging evidence supporting the feasibility, tolerability, and potential efficacy of combined immunomodulatory strategies, thereby contributing to the evolving paradigm of personalized and immune-guided management in IMDs. Future work should focus on biomarker-guided patient selection, rigorous monitoring, and determining the optimal timing for therapy initiation. Integrating immunological profiling into patient assessment may enable more precise, stratified therapeutic approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/mbio.00230-26","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T13:00:20Z","timestamp":1779454820000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":5,"title":["Emerging evidence for anti-PD-1 and IFN-\u03b3 as adjunctive immunotherapy in invasive mold infections"],"prefix":"10.1128","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7444-4662","authenticated-orcid":true,"given":"Alexandra","family":"Serris","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05f82e368","id-type":"ROR","asserted-by":"publisher"}],"name":"Infectious Diseases Department, Universitary Hospial Necker-Enfants Malades, Assistance Publique-H\u00f4pitaux de Paris, Paris Cit\u00e9 University","place":["Paris, France"]},{"id":[{"id":"https:\/\/ror.org\/05f82e368","id-type":"ROR","asserted-by":"publisher"}],"name":"Translational Immunology Unit, Institut Pasteur, Universit\u00e9 Paris Cit\u00e9","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Guihot","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00x9ewr78","id-type":"ROR","asserted-by":"publisher"}],"name":"Sorbonne Universit\u00e9, Inserm, U1135, CNRS ERL8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris)","place":["Paris, France"]},{"id":[{"id":"https:\/\/ror.org\/00pg5jh14","id-type":"ROR","asserted-by":"publisher"}],"name":"Immunology Department, Universitary Hospital Piti\u00e9-Salp\u00eatri\u00e8re, Assistance Publique-H\u00f4pitaux de Paris","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremie","family":"Joffre","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02en5vm52","id-type":"ROR","asserted-by":"publisher"}],"name":"Medical Intensive Care Unit, H\u00f4pital Saint-Antoine, Assistance Publique-H\u00f4pitaux de Paris, Sorbonne Universit\u00e9","place":["Paris, France"]},{"id":[{"id":"https:\/\/ror.org\/01875pg84","id-type":"ROR","asserted-by":"publisher"}],"name":"Inserm UMRS 938\u2014Immune System and Neuro-Inflammation, H\u00f4pital Saint-Antoine","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Dessajan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05f82e368","id-type":"ROR","asserted-by":"publisher"}],"name":"Medical and Infectious Diseases ICU, Paris Cit\u00e9 University\u2014Bichat University Hospital, Assistance Publique\u2014H\u00f4pitaux de Paris","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laureen","family":"Dahuron","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Regional Universitary Tours Hospital","place":["Tours, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexie","family":"Bosch","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Chamb\u00e9ry Hospital","place":["Chamb\u00e9ry, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Dudoignon","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05f82e368","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Anesthesiology and Critical Care and Burn Unit, Groupe Hospitalier St Louis-Lariboisi\u00e8re, Assistance Publique\u2014H\u00f4pitaux de Paris (AP\u2014HP), Universit\u00e9 Paris-Cit\u00e9","place":["Paris, France"]},{"id":[{"id":"https:\/\/ror.org\/02vjkv261","id-type":"ROR","asserted-by":"publisher"}],"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), INSERM UMR-S 942 Mascot, Lariboisi\u00e8re Hospital","place":["Paris, France"]},{"name":"FHU PROMICE","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucien","family":"Pierot","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Rangueil University Hospital","place":["Toulouse, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Leli\u00e8vre","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01ahyrz84","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Infectious and Tropical Diseases, Toulouse University Hospital","place":["Toulouse, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Claire","family":"Lukaszewicz","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01502ca60","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Anesthesiology and Critical Care, Neuroscience Research Center, Hospices Civils de Lyon, H\u00f4pital Neurologique Pierre Wertheimer and Universit\u00e9 Lyon 1","place":["Lyon, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Monneret","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01502ca60","id-type":"ROR","asserted-by":"publisher"}],"name":"Immunology Laboratory, Hospices Civils de Lyon","place":["Lyon, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lambotte","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, AP-HP, GHU Paris Saclay","place":["Le Kremlin Bic\u00eatre, France"]},{"id":[{"id":"https:\/\/ror.org\/02vjkv261","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological, Bacterial Diseases (IMVA-HB\/IDMIT\/UMRS1184)","place":["Le Kremlin Bic\u00eatre, France"]},{"name":"IHU Sepsis Comprehensive Center","place":["Garches, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Martin-blondel","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01ahyrz84","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Infectious and Tropical Diseases, Toulouse University Hospital","place":["Toulouse, France"]},{"id":[{"id":"https:\/\/ror.org\/00n90tt57","id-type":"ROR","asserted-by":"publisher"}],"name":"Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, Toulouse III University","place":["Toulouse, France"]},{"id":[{"id":"https:\/\/ror.org\/01ahyrz84","id-type":"ROR","asserted-by":"publisher"}],"name":"Neo-I3D Research Group, Toulouse University Hospital","place":["Toulouse, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Lanternier","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05f82e368","id-type":"ROR","asserted-by":"publisher"}],"name":"Infectious Diseases Department, Universitary Hospial Necker-Enfants Malades, Assistance Publique-H\u00f4pitaux de Paris, Paris Cit\u00e9 University","place":["Paris, France"]},{"id":[{"id":"https:\/\/ror.org\/05f82e368","id-type":"ROR","asserted-by":"publisher"}],"name":"National Reference Center for Invasive Mycoses and Antifungals, Translational Mycology Research Group, Mycology Department, Institut Pasteur, Universit\u00e9 Paris Cit\u00e9","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/myc.70044"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2021.12.009"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-166"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa264"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.838344"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700840"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1347318"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30541-2"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000530"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.900522"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mmcr.2022.06.003"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2022.06.035"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1608828"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2024.116653"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1082084"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-061121-040214"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.941079"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.883638"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1018202"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6145-8"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adn9879"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-019-05704-z"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k793"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03993-0"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.05069.x"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03094.x"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.7150\/jca.65012"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0221-9"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.678771"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.24175"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103004"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.112"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26512"}],"container-title":["mBio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/mbio.00230-26","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/mbio.00230-26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T13:03:43Z","timestamp":1782392623000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/mbio.00230-26"}},"subtitle":[],"editor":[{"given":"Martin","family":"Hoenigl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,10]]}},"alternative-id":["10.1128\/mbio.00230-26"],"URL":"https:\/\/doi.org\/10.1128\/mbio.00230-26","relation":{},"ISSN":["2150-7511"],"issn-type":[{"value":"2150-7511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"2026-01-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00230-26"}}